Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection

IF 4.2 2区医学 Q1 INFECTIOUS DISEASES

Expert Review of Anti-infective Therapy Pub Date : 2024-09-13 DOI:10.1080/14787210.2024.2403147

Ricardo A. Loaiza, Mónica A. Farías, Catalina A. Andrade, Mario A. Ramírez, Linmar Rodriguez-Guilarte, José T. Muñóz, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis

引用次数: 0

Abstract

The human respiratory syncytial virus (hRSV) is one of childhood diseases’ most common respiratory pathogens and is highly associated with lower respiratory tract infections. The dramatic peak in d...

查看原文本刊更多论文

治疗婴儿呼吸道合胞病毒感染的免疫调节标记物和疗法

人类呼吸道合胞病毒（hRSV）是儿童疾病中最常见的呼吸道病原体之一，与下呼吸道感染密切相关。人类呼吸道合胞病毒（hRSV）是儿童疾病中最常见的呼吸道病原体之一，与下呼吸道感染高度相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Anti-infective Therapy 医学-药学

CiteScore

11.20

自引率

0.00%

发文量

审稿时长

4-8 weeks

期刊介绍： Expert Review of Anti-Infective Therapy (ISSN 1478-7210) provides expert reviews on therapeutics and diagnostics in the treatment of infectious disease. Coverage includes antibiotics, drug resistance, drug therapy, infectious disease medicine, antibacterial, antimicrobial, antifungal and antiviral approaches, and diagnostic tests.